New cobas(R) 4800 System designed to increase laboratory efficiency and medical value Roche Diagnostics Canada (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of a new Health Canada approved ...

Roche, a leader in research-focused healthcare, announced the commercial availability of the cobas HIV-1, HCV and HCV Genotyping (GT) assays in countries accepting the CE mark. These new molecular ...

Roche has announced the commercial availability of the cobas HIV-1, HCV and HCV Genotyping (GT) assays in countries accepting the CE mark. These new molecular diagnostic assays increase the available ...

- CMV viral load testing is used to assess how solid organ and hematopoietic stem cell transplant patients on therapy are responding to treatment PLEASANTON, California, June 21, 2017 /PRNewswire/ -- ...

PLEASANTON, Calif., Feb. 13, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA clearance for the cobas® Factor II and Factor V Test for use on the cobas® ...

New process allows labs to use same Pap test vial instead of transferring sample to new vial, thus simplifying workflow INDIANAPOLIS, June 26, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ...

Please provide your email address to receive an email when new articles are posted on . Roche Diagnostics announced the release of new assays for HIV-1, hepatitis C virus infection and genotyping ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announces an expanded CE mark indication for the cobas® 4800 HPV Test. The newly expanded indication for the cobas® 4800 HPV Test as a primary screen means Pap ...

Please provide your email address to receive an email when new articles are posted on . Roche Molecular Diagnostics announced the release of its new assay for hepatitis B virus infection, the cobas ...

Roche announced that the U.S. FDA has approved a new, more efficient workflow process for the cobas HPV Test, allowing sample processing from the primary sample collection vial after it has been used ...